• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的胃肠道受累:病理生理学、诊断与管理

Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management.

作者信息

Warnecke T, Schäfer K-H, Claus I, Del Tredici K, Jost W H

机构信息

Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, 48149, Münster, Germany.

Research and Transfer Working Group Enteric Nervous System (AGENS), University of Applied Sciences Kaiserslautern, Campus Zweibrücken, 66482, Zweibrücken, Germany.

出版信息

NPJ Parkinsons Dis. 2022 Mar 24;8(1):31. doi: 10.1038/s41531-022-00295-x.

DOI:10.1038/s41531-022-00295-x
PMID:35332158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948218/
Abstract

Growing evidence suggests an increasing significance for the extent of gastrointestinal tract (GIT) dysfunction in Parkinson's disease (PD). Most patients suffer from GIT symptoms, including dysphagia, sialorrhea, bloating, nausea, vomiting, gastroparesis, and constipation during the disease course. The underlying pathomechanisms of this α-synucleinopathy play an important role in disease development and progression, i.e., early accumulation of Lewy pathology in the enteric and central nervous systems is implicated in pharyngeal discoordination, esophageal and gastric motility/peristalsis impairment, chronic pain, altered intestinal permeability and autonomic dysfunction of the colon, with subsequent constipation. Severe complications, including malnutrition, dehydration, insufficient drug effects, aspiration pneumonia, intestinal obstruction, and megacolon, frequently result in hospitalization. Sophisticated diagnostic tools are now available that permit more detailed examination of specific GIT impairment patterns. Furthermore, novel treatment approaches have been evaluated, although high-level evidence trials are often missing. Finally, the burgeoning literature devoted to the GIT microbiome reveals its importance for neurologists. We review current knowledge about GIT pathoanatomy, pathophysiology, diagnosis, and treatment in PD and provide recommendations for management in daily practice.

摘要

越来越多的证据表明,胃肠道(GIT)功能障碍在帕金森病(PD)中的程度日益重要。大多数患者在病程中会出现胃肠道症状,包括吞咽困难、流涎、腹胀、恶心、呕吐、胃轻瘫和便秘。这种α-突触核蛋白病的潜在病理机制在疾病的发生和发展中起着重要作用,即路易体病理在肠道和中枢神经系统的早期积累与咽部协调障碍、食管和胃动力/蠕动受损、慢性疼痛、肠道通透性改变以及结肠自主神经功能障碍有关,随后导致便秘。严重并发症,包括营养不良、脱水、药物疗效不佳、吸入性肺炎、肠梗阻和巨结肠,经常导致住院。现在有了精密的诊断工具,可以对特定的胃肠道损伤模式进行更详细的检查。此外,尽管往往缺乏高水平证据的试验,但已经对新的治疗方法进行了评估。最后,关于胃肠道微生物群的新兴文献揭示了其对神经科医生的重要性。我们回顾了目前关于帕金森病中胃肠道病理解剖、病理生理、诊断和治疗的知识,并为日常实践中的管理提供建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/9749144f084c/41531_2022_295_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/83e0d15ea958/41531_2022_295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/e161e0bb1b1a/41531_2022_295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/a91e9d2abcad/41531_2022_295_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/9749144f084c/41531_2022_295_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/83e0d15ea958/41531_2022_295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/e161e0bb1b1a/41531_2022_295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/a91e9d2abcad/41531_2022_295_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/301c/8948218/9749144f084c/41531_2022_295_Fig4_HTML.jpg

相似文献

1
Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management.帕金森病的胃肠道受累:病理生理学、诊断与管理
NPJ Parkinsons Dis. 2022 Mar 24;8(1):31. doi: 10.1038/s41531-022-00295-x.
2
Gut dysfunction in Parkinson's disease.帕金森病中的肠道功能障碍。
World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742.
3
Gastrointestinal Dysfunction in Parkinson's Disease.帕金森病中的胃肠功能障碍
Curr Treat Options Neurol. 2018 Oct 25;20(12):54. doi: 10.1007/s11940-018-0539-9.
4
Gastric electrical stimulation: an evidence-based analysis.胃电刺激:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1.
5
The Gut and Nonmotor Symptoms in Parkinson's Disease.帕金森病中的肠道与非运动症状
Int Rev Neurobiol. 2017;134:787-809. doi: 10.1016/bs.irn.2017.05.027. Epub 2017 Jul 3.
6
Gastro-intestinal dysfunctions in Parkinson's disease (Review).帕金森病中的胃肠功能障碍(综述)
Exp Ther Med. 2021 Oct;22(4):1083. doi: 10.3892/etm.2021.10517. Epub 2021 Jul 29.
7
Gastrointestinal Autonomic Dysfunction in Patients with Parkinson's Disease.帕金森病患者的胃肠道自主神经功能障碍。
J Mov Disord. 2015 May;8(2):76-82. doi: 10.14802/jmd.15008. Epub 2015 May 31.
8
Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis.帕金森病与肠道:早期诊断的未来展望
Front Neurosci. 2020 Jun 17;14:626. doi: 10.3389/fnins.2020.00626. eCollection 2020.
9
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.帕金森病自主神经功能障碍评定量表:流涎、吞咽困难和便秘——帕金森病评定量表运动障碍特别工作组的评论与建议
Mov Disord. 2009 Apr 15;24(5):635-46. doi: 10.1002/mds.22260.
10
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.帕金森病中的胃肠功能障碍:发生率与病理生理学
Neurology. 1992 Apr;42(4):726-32. doi: 10.1212/wnl.42.4.726.

引用本文的文献

1
Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut to Relieve Parkinson's Disease.Gpr35表达减轻神经炎症并丰富肠道菌群以缓解帕金森病。
Research (Wash D C). 2025 Aug 25;8:0846. doi: 10.34133/research.0846. eCollection 2025.
2
Associations of digestive diseases exposure and lifestyle factors with Parkinson's disease.消化系统疾病暴露及生活方式因素与帕金森病的关联
NPJ Parkinsons Dis. 2025 Aug 18;11(1):245. doi: 10.1038/s41531-025-01098-6.
3
Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets.

本文引用的文献

1
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease.在帕金森病纵向队列研究中,肠道细菌酪氨酸脱羧酶与临床变量相关。
NPJ Parkinsons Dis. 2021 Dec 15;7(1):115. doi: 10.1038/s41531-021-00260-0.
2
Association between Parkinson's disease and the faecal eukaryotic microbiota.帕金森病与粪便真核微生物群之间的关联。
NPJ Parkinsons Dis. 2021 Nov 18;7(1):101. doi: 10.1038/s41531-021-00244-0.
3
The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
衡量帕金森病研究和吞咽困难中的关键因素:核心结局集的必要性。
Mov Disord. 2025 Jul;40(7):1260-1264. doi: 10.1002/mds.30241. Epub 2025 May 23.
4
Nature's Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson's Disease.大自然的疗法:探索蜂胶缓解帕金森病非运动症状的潜力。
Molecules. 2025 Apr 8;30(8):1672. doi: 10.3390/molecules30081672.
5
Gut neuropeptide involvement in Parkinson's disease.肠道神经肽与帕金森病的关系。
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G716-G733. doi: 10.1152/ajpgi.00383.2024. Epub 2025 Apr 25.
6
Sex Specific Effects of Environmental Toxin-Derived Alpha Synuclein on Enteric Neuronal-Epithelial Interactions.环境毒素衍生的α-突触核蛋白对肠神经元-上皮相互作用的性别特异性影响。
Neurogastroenterol Motil. 2025 Jul;37(7):e70046. doi: 10.1111/nmo.70046. Epub 2025 Apr 24.
7
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗:贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
8
TNF-α disrupts the malate-aspartate shuttle, driving metabolic rewiring in iPSC-derived enteric neural lineages from Parkinson's Disease patients.肿瘤坏死因子-α破坏苹果酸-天冬氨酸穿梭途径,驱动帕金森病患者诱导多能干细胞衍生的肠神经谱系中的代谢重编程。
bioRxiv. 2025 Mar 26:2025.03.25.644826. doi: 10.1101/2025.03.25.644826.
9
Imaging the enteric nervous system.对肠神经系统进行成像。
Front Neuroanat. 2025 Mar 12;19:1532900. doi: 10.3389/fnana.2025.1532900. eCollection 2025.
10
Advances in autonomic dysfunction research in Parkinson's disease.帕金森病自主神经功能障碍研究进展
Front Aging Neurosci. 2025 Mar 12;17:1468895. doi: 10.3389/fnagi.2025.1468895. eCollection 2025.
肠道微生物群与帕金森病的关联:以α-突触核蛋白转运为重点的系统机制综述。
Brain Res. 2021 Oct 15;1769:147609. doi: 10.1016/j.brainres.2021.147609. Epub 2021 Aug 8.
4
Fecal microbiota transplant as a potential treatment for Parkinson's disease - A case series.粪便微生物群移植作为帕金森病的一种潜在治疗方法 - 病例系列。
Clin Neurol Neurosurg. 2021 Aug;207:106791. doi: 10.1016/j.clineuro.2021.106791. Epub 2021 Jun 30.
5
Vagus Nerve and Stomach Synucleinopathy in Parkinson's Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the "Body-First" Hypothesis.迷走神经和胃突触核蛋白病在帕金森病、偶发路易体病和正常老年人群中的表现:对“先体后病”假说的否定证据。
J Parkinsons Dis. 2021;11(4):1833-1843. doi: 10.3233/JPD-212733.
6
Early constipation predicts faster dementia onset in Parkinson's disease.早期便秘预示帕金森病患者痴呆发病更快。
NPJ Parkinsons Dis. 2021 May 26;7(1):45. doi: 10.1038/s41531-021-00191-w.
7
Expiratory Muscle Strength Training for Therapy of Pharyngeal Dysphagia in Parkinson's Disease.呼吸肌力量训练治疗帕金森病咽期吞咽障碍。
Mov Disord. 2021 Aug;36(8):1815-1824. doi: 10.1002/mds.28552. Epub 2021 Mar 2.
8
Effect of Capsaicinoids on Neurophysiological, Biochemical, and Mechanical Parameters of Swallowing Function.辣椒素类物质对吞咽功能的神经生理、生化和力学参数的影响。
Neurotherapeutics. 2021 Apr;18(2):1360-1370. doi: 10.1007/s13311-020-00996-2. Epub 2021 Jan 15.
9
Seeding Propensity and Characteristics of Pathogenic αSyn Assemblies in Formalin-Fixed Human Tissue from the Enteric Nervous System, Olfactory Bulb, and Brainstem in Cases Staged for Parkinson's Disease.帕金森病分期病例的肠神经、嗅球和脑干福尔马林固定人组织中致病性 α 突触核蛋白聚集体的播散倾向和特征。
Cells. 2021 Jan 12;10(1):139. doi: 10.3390/cells10010139.
10
Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease.与肠道稳态相关的单核苷酸多态性影响帕金森病的风险和发病年龄。
Front Aging Neurosci. 2020 Nov 17;12:603849. doi: 10.3389/fnagi.2020.603849. eCollection 2020.